Literature DB >> 16379602

Short communication: Influence of active tuberculosis on chemokine and chemokine receptor expression in HIV-infected persons.

Luke Elizabeth Hanna1, Jagadish Chandra Bose, Kaustuv Nayak, Sudha Subramanyam, Soumya Swaminathan.   

Abstract

Tuberculosis (TB) is the major opportunistic infection of HIV-1-infected patients in developing countries. Concurrent infection with TB results in immune cells having enhanced susceptibility to HIV-1 infection, which facilitates entry and replication of the virus. Cumulative data from earlier studies indicate that TB provides a milieu of continuous cellular activation and irregularities in cytokine and chemokine circuits that favor viral replication and disease progression. To better understand the interaction of the host with HIV-1 during active tuberculosis, we investigated in vivo expression of the HIV-1 coreceptors, CCR5 and CXCR4, and circulating levels of the inhibitory beta-chemokines, macrophage inflammatory protein-1-alpha (MIP-1alpha), macrophage inflammatory protein-1-beta (MIP-1beta), and regulated upon activation T cell expressed and secreted (RANTES), in HIV-positive individuals with and without active pulmonary tuberculosis. We found a significant decrease from normal in the fraction of CD4+ T cells expressing CCR5 and CXCR4 in individuals infected with HIV. However, CCR5 and CXCR4 expression did not differ significantly between HIV patients with and without tuberculosis. Higher amounts of MIP-1alpha, MIP-1beta, and RANTES were detected in plasma of HIV-1-positive individuals, particularly those with dual infection, although the increase was not found to be statistically significant.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16379602     DOI: 10.1089/aid.2005.21.997

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  1 in total

1.  IP-10 detection in urine is associated with lung diseases.

Authors:  Angela Cannas; Ludovica Calvo; Teresa Chiacchio; Gilda Cuzzi; Valentina Vanini; Francesco N Lauria; Luigia Pucci; Enrico Girardi; Delia Goletti
Journal:  BMC Infect Dis       Date:  2010-11-22       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.